Respiratory Medicine
Volume 104, Issue 9 , Pages 1288-1296 , September 2010

Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD

  • Danilo C. Berton

      Affiliations

    • Pulmonary Function and Clinical Exercise Physiology Unit (SEFICE); Respiratory Division, Department of Medicine; Federal University of Sao Paulo – Paulista School of Medicine (UNIFESP-EPM), Rua Professor Francisco de Castro 54, Vila Clementino, CEP: 04020-050, Sao Paulo, Brazil
    • Health Science Institute, Feevale University, Novo Hamburgo, Brazil
    • DCB was supported by a PhD Fellowship Grant from CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), Brazil.
    • Corresponding Author InformationCorresponding authors. Tel.: +55 11 5571 8384; fax: +55 11 5575 2843.
    • ,
  • Michel Reis

      Affiliations

    • Pulmonary Function and Clinical Exercise Physiology Unit (SEFICE); Respiratory Division, Department of Medicine; Federal University of Sao Paulo – Paulista School of Medicine (UNIFESP-EPM), Rua Professor Francisco de Castro 54, Vila Clementino, CEP: 04020-050, Sao Paulo, Brazil
    • ,
  • Ana Cristina B. Siqueira

      Affiliations

    • Pulmonary Function and Clinical Exercise Physiology Unit (SEFICE); Respiratory Division, Department of Medicine; Federal University of Sao Paulo – Paulista School of Medicine (UNIFESP-EPM), Rua Professor Francisco de Castro 54, Vila Clementino, CEP: 04020-050, Sao Paulo, Brazil
    • ,
  • Adriano C. Barroco

      Affiliations

    • Pulmonary Function and Clinical Exercise Physiology Unit (SEFICE); Respiratory Division, Department of Medicine; Federal University of Sao Paulo – Paulista School of Medicine (UNIFESP-EPM), Rua Professor Francisco de Castro 54, Vila Clementino, CEP: 04020-050, Sao Paulo, Brazil
    • ,
  • Luciana S. Takara

      Affiliations

    • Pulmonary Function and Clinical Exercise Physiology Unit (SEFICE); Respiratory Division, Department of Medicine; Federal University of Sao Paulo – Paulista School of Medicine (UNIFESP-EPM), Rua Professor Francisco de Castro 54, Vila Clementino, CEP: 04020-050, Sao Paulo, Brazil
    • ,
  • Daniela M. Bravo

      Affiliations

    • Pulmonary Function and Clinical Exercise Physiology Unit (SEFICE); Respiratory Division, Department of Medicine; Federal University of Sao Paulo – Paulista School of Medicine (UNIFESP-EPM), Rua Professor Francisco de Castro 54, Vila Clementino, CEP: 04020-050, Sao Paulo, Brazil
    • ,
  • Solange Andreoni

      Affiliations

    • Department of Preventive and Social Medicine; Federal University of Sao Paulo (UNIFESP), Sao Paulo, Brazil
    • ,
  • J. Alberto Neder

      Affiliations

    • Pulmonary Function and Clinical Exercise Physiology Unit (SEFICE); Respiratory Division, Department of Medicine; Federal University of Sao Paulo – Paulista School of Medicine (UNIFESP-EPM), Rua Professor Francisco de Castro 54, Vila Clementino, CEP: 04020-050, Sao Paulo, Brazil
    • JAN is an Established Investigator (level II) of the CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico), Brazil.
    • Corresponding Author InformationCorresponding authors. Tel.: +55 11 5571 8384; fax: +55 11 5575 2843.

Received 6 March 2010 ,Accepted 24 May 2010.

References 

  1. Celli BR. Update on the management of COPD. Chest. 2008;133:1451–1462
  2. Global Strategy for the Diagnosis . Management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD). Available from: http://www.goldcopd.org2007;
  3. Lötvall J. Pharmacological similarities and differences between β2-agonists. Respir Med. 2001;95S:S7–S11
  4. O’Donnell DE, Fluge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004;23:832–840
  5. Maltais F, Hamilton A, Marciniuk D, Hernandez P, Sciurba FC, Richter K, et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest. 2005;128:1168–1178
  6. Neder JA, Fuld JP, Overend T, Thirlwell J, Carter R, Stevenson R, et al. Effects of formoterol on exercise tolerance in severely disabled patients with COPD. Respir Med. 2007;101:2056–2064
  7. Cazzola M, Di Marco F, Santus P, Boveri B, Verga M, Matera MG, et al. The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD. Pulm Pharmacol Ther. 2004;17:35–39
  8. Tennant RC, Erin EM, Barnes PJ, Hansel TT. Long-acting beta2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?. Curr Opin Pharmacol. 2003;3:270–276
  9. van Noord JA, Aumann JL, Janssens E, Smeets JJ, Verhaert J, Disse B, et al. Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. Eur Respir J. 2005;26:214–222
  10. van Noord JA, Aumann JL, Janssens E, Verhaert J, Smeets JJ, Mueller A, et al. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. Chest. 2006;129:509–517
  11. Tashkin DP, Littner M, Andrews CP, Tomlinson L, Rinehart M, Denis-Mize K. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial. Respir Med. 2008;102:479–487
  12. Vogelmeier C, Kardos P, Harari S, Gans SJ, Stenglein S, Thirlwell J. Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study. Respir Med. 2008;102:1511–1520
  13. Tashkin DP, Donohue JF, Mahler DA, Huang H, Goodwin E, Schaefer K, et al. Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD. Respir Med. 2009;103:516–524
  14. Tashkin DP, Hanania NA, McGinty J, Denis-Mize K, Chaudry I. Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease. Adv Ther. 2009;26:1024–1034
  15. Hanania NA, Boota A, Kerwin E, Tomlinson L, Denis-Mize K. Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide. Drugs. 2009;69:1205–1216
  16. O’Donnell DE. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3:180–184
  17. Cooper CB. Airflow obstruction and exercise. Respir Med. 2009;103:325–334
  18. Kaplan RM, Ries AL, Reilly J, Mohsenifar Z. Measurement of health-related quality of life in the National Emphysema Treatment Trial. Chest. 2004;126:781–789
  19. Brown CD, Benditt JO, Sciurba FC, Lee SM, Criner GJ, Mosenifar Z, et al. Exercise testing in severe emphysema: association with quality of life and lung function. COPD. 2008;5:117–124
  20. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984;85:751–758
  21. Neder JA, Andreoni S, Castelo-Filho A, Nery LE. Reference values for lung function tests. I. Static volumes. Braz J Med Biol Res. 1999;32:703–717
  22. Neder JA, Andreoni S, Peres C, Nery LE. Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfer factor). Braz J Med Biol Res. 1999;32:729–737
  23. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377–381
  24. Casaburi R, Kukafka D, Cooper CB, Witek TJ, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005;127:809–817
  25. Casaburi R. Factors determining constant work rate exercise tolerance in COPD and their role in dictating the minimal clinically important difference in response to interventions. COPD. 2005;2:131–136
  26. Puente-Maestu L, Villar F, de Miguel J, Stringer WW, Sanz P, Sanz ML, et al. Clinical relevance of constant power exercise duration changes in COPD. Eur Respir J. 2009;34:340–345
  27. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–968
  28. Mahler DA. Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3:234–238
  29. O’Donnell DE, Laveneziana P. The clinical importance of dynamic lung hyperinflation in COPD. COPD. 2006;3:219–232
  30. O’Donnell DE, Hamilton AL, Webb KA. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. J Appl Physiol. 2006;101:1025–1035
  31. Mahler DA, Fierro-Carrion G, Mejia-Alfaro R, Ward J, Baird JC. Responsiveness of continuous ratings of dyspnea during exercise in patients with COPD. Med Sci Sports Exerc. 2005;37:529–535
  32. Mahler DA, Mejia-Alfaro R, Ward J, Baird JC. Continuous measurement of breathlessness during exercise: validity, reliability, and responsiveness. J Appl Physiol. 2001;90:2188–2196
  33. Fierro-Carrion G, Mahler DA, Ward J, Baird JC. Comparison of continuous and discrete measurements of dyspnea during exercise in patients with COPD and normal subjects. Chest. 2004;125:77–84
  34. Gross NJ, Co E, Skorodin MS. Cholinergic bronchomotor tone in COPD. Estimates of its amount in comparison with that in normal subjects. Chest. 1989;96:984–987
  35. Umeda N, Yoshikawa T, Kanazawa H, Hirata K, Fujimoto S. Association of beta2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD. Respirology. 2008;13:346–352
  36. Pepin V, Saey D, Whittom F, LeBlanc P, Maltais F. Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:1517–1522
  37. Neder JA, Jones PW, Nery LE, Whipp BJ. Determinants of the exercise endurance capacity in patients with chronic obstructive pulmonary disease. The power-duration relationship. Am J Respir Crit Care Med. 2000;162:497–504
  38. Tashkin DP, Pearle J, Iezzoni D, Varghese ST. Formoterol and tiotropium compared with tiotropium alone for treatment of COPD. COPD. 2009;6:17–25

PII: S0954-6111(10)00253-2

doi: 10.1016/j.rmed.2010.05.017

Respiratory Medicine
Volume 104, Issue 9 , Pages 1288-1296 , September 2010

Article Tools

* Image Usage & Resolution